Drug
Shr4640
Shr4640: highest development phase Phase 2, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| SHR4640 tablet NCT05513976 | Phase 2 | Primary Gout and Hyperuricemia |
Latest
No recent events.
Follow Shr4640 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.